Scientists from the Uniformed Services University of the Health Sciences (USU) have discovered that diets high in salt may increase the virulence of the pathogen Helicobacter pylori (H. pylori), which is the most common cause of ulcers in the stomach and duodenum.
The Health Protection Agency is carrying out an investigation into a rise in the number of human cases of Salmonella Senftenberg.
Researchers at Boston University School of Medicine (BUSM) and McLean Hospital have found that practicing yoga may elevate brain gamma-aminobutyric (GABA) levels, the brain?s primary inhibitory neurotransmitter.
A new report released by the Australian Institute of Health and Welfare (AIHW) and the Australian Transport Safety Bureau (ATSB) examines transportation-related injuries and deaths of Aboriginal and Torres Strait Islander Australians in Queensland, Western Australia, South Australia and the Northern Territory.
Researchers have deciphered how neurotransmitter transporter proteins recognise their targets, a finding which may provide clues for better design of drugs used to treat depression.
A Northwestern University study reports reassuring news for millions of patients with drug-coated stents to treat coronary artery blockages. The medicated stents are generally safe and effective whether they are used for blockages approved by the FDA or for more complicated conditions not specifically approved.
South Australian research which found a link between cerebral palsy and exposure to herpes viruses has been recognised as among the most significant of the past year by an international panel of neuroscientists.
New research by Australian scientists, soon to be published in the international Accident Analysis and Prevention journal, has shown that drivers carrying two or more passengers are twice as likely to crash as unaccompanied drivers.
University of Melbourne scientist Professor Graeme Clark has received the 2007 Klaus Joachim Zulch prize for his research into neuroscience and the Cochlear implant, giving hearing to deaf people.
Early-stage research has found that a new gene therapy can nearly eliminate arthritis pain, and significantly reduce long-term damage to the affected joints, according to a study published in the journal Arthritis and Rheumatism.